A practical guide for the use of apalutamide for non-metastatic castration-resistant prostate cancer in Australia.
Studies of patients with castrate-resistant prostate cancer at high risk of developing overt metastases but with no current evidence of evaluable disease on computed tomography or bone scan non-metastatic castrate-resistant prostrate cancer have …